![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Completes $60 Million Note Offering Secured by Argatroban Royalties
06 févr. 2007 16h05 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Feb. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that its newly formed, wholly-owned subsidiary has closed a private placement of $60 million in...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Presentation/Webcast At BIO CEO Conference
05 févr. 2007 16h35 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Feb. 5, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it will participate in the 9th Annual BIO CEO & Investor Conference, taking place February...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Conference Call to Discuss Fourth Quarter and Year End 2006 Results
30 janv. 2007 08h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 30, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Friday, March 9, 2007 at 8:00 a.m. ET to discuss its fourth quarter and year...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Presentation/Webcast At 25th Annual JPMorgan Healthcare Conference
04 janv. 2007 08h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 4, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it will participate in the 25th Annual JPMorgan Healthcare Conference, taking place January 8-11,...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
FDA Accepts Encysive's Complete Response to THELIN New Drug Application
28 déc. 2006 13h53 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 28, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's complete...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Announces Launch of Thelin in Germany
18 déc. 2006 02h30 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 18, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets are now commercially available in Germany for...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals' THELIN (sitaxentan sodium) Receives Positive Opinion From Australian Health Authority
15 déc. 2006 13h47 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 15, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the Australian Drug Evaluation Committee (ADEC) of the Therapeutic Goods Administration (TGA)...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Submits Response to FDA For Thelin New Drug Application
14 déc. 2006 21h03 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 14, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced it has provided the information requested by the U.S. Food and Drug Administration (FDA) in its letter...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Expects to Submit Revised Response to Thelin Approvable Letter Within Several Days
14 déc. 2006 08h35 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 14, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) announced today that the U.S. Food and Drug Administration (FDA) informed the Company that its response to the...
![Encysive Pharmaceuticals Inc.](/news-release/logo/214857/0/214857.jpg?lastModified=12%2F09%2F2016%2022%3A57%3A00&size=2)
Encysive Pharmaceuticals Receives FDA Clearance to Resume Clinical Studies With TBC3711
07 déc. 2006 18h45 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 7, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to initiate and resume...